Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

National Healthcare (NHC) Shares Outstanding (Diluted Average) (2016 - 2025)

National Healthcare (NHC) has disclosed Shares Outstanding (Diluted Average) for 16 consecutive years, with $15.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) changed 0.31% year-over-year to $15.6 million, compared with a TTM value of $15.6 million through Dec 2025, changed 0.31%, and an annual FY2025 reading of $15.6 million, changed 0.31% over the prior year.
  • Shares Outstanding (Diluted Average) was $15.6 million for Q4 2025 at National Healthcare, roughly flat from $15.7 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $15.7 million in Q3 2024 and bottomed at $15.3 million in Q2 2023.
  • Average Shares Outstanding (Diluted Average) over 5 years is $15.5 million, with a median of $15.4 million recorded in 2022.
  • The sharpest move saw Shares Outstanding (Diluted Average) dropped 0.45% in 2023, then increased 2.17% in 2024.
  • Year by year, Shares Outstanding (Diluted Average) stood at $15.4 million in 2021, then grew by 0.2% to $15.4 million in 2022, then dropped by 0.45% to $15.4 million in 2023, then grew by 1.44% to $15.6 million in 2024, then increased by 0.31% to $15.6 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for NHC at $15.6 million in Q4 2025, $15.7 million in Q3 2025, and $15.6 million in Q2 2025.